---
title: "減肥藥物開發商 Kailera 在納斯達克首次亮相中股價飆升 62.5%"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/283179748.md"
description: "4 月 17 日（路透社）- Kailera Therapeutics 在週五的納斯達克首秀中股價上漲了 62.5%，該減肥藥開發公司在美國首次公開募股中籌集了 6.25 億美元。（班加羅爾的 Manya Saini 報道；Sahal Muhammed 編輯）"
datetime: "2026-04-17T17:27:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283179748.md)
  - [en](https://longbridge.com/en/news/283179748.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283179748.md)
---

# 減肥藥物開發商 Kailera 在納斯達克首次亮相中股價飆升 62.5%

April 17 (Reuters) - Kailera Therapeutics' shares rose 62.5% in their Nasdaq debut on Friday after the weight-loss drug developer raised $625 million in its U.S. initial public offering. (Reporting by Manya Saini in Bengaluru; Editing by Sahal Muhammed)

### 相關股票

- [GRTX.US](https://longbridge.com/zh-HK/quote/GRTX.US.md)
- [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/zh-HK/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [ARKG.US](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [NDAQ.US](https://longbridge.com/zh-HK/quote/NDAQ.US.md)

## 相關資訊與研究

- [巨生醫獲 SelectUSA 醫療科技組金牌 啟動美國 A 輪募資目標 1000 萬美元](https://longbridge.com/zh-HK/news/286905054.md)
- [鉅亨速報 - Factset 最新調查：Roivant Sciences LtdROIV-US 的目標價調升至 38 元，幅度約 8.57%](https://longbridge.com/zh-HK/news/287126179.md)
- [儲局會議記錄顯示 大多數官員警告通脹率若持續高於 2%  需考慮加息](https://longbridge.com/zh-HK/news/287171073.md)
- [“搞錢”，才是 Revolution 千億神話密碼](https://longbridge.com/zh-HK/news/286888792.md)
- [Relay Therapeutics 期權交易量異常大（NASDAQ:RLAY）](https://longbridge.com/zh-HK/news/287085881.md)